Diabetes and covid-19: a global health challenge.
作者信息
Shenoy Akhil, Ismaily Mehwish, Bajaj Mandeep
机构信息
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
出版信息
BMJ Open Diabetes Res Care. 2020 Apr;8(1). doi: 10.1136/bmjdrc-2020-001450.
Abstract
摘要
相似文献
1
Diabetes and covid-19: a global health challenge.糖尿病与新冠疫情：一项全球健康挑战。
BMJ Open Diabetes Res Care. 2020 Apr;8(1). doi: 10.1136/bmjdrc-2020-001450.
2
SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health.严重急性呼吸综合征冠状病毒2（SARS-CoV-2），即导致2019冠状病毒病（COVID-19）的病毒：细胞计数法与全球健康面临的新挑战
Cytometry A. 2020 Apr;97(4):340-343. doi: 10.1002/cyto.a.24002. Epub 2020 Mar 18.
3
COVID-19 and diabetes: a co-conspiracy?2019冠状病毒病与糖尿病：一种共同的“阴谋”？
Lancet Diabetes Endocrinol. 2020 Oct;8(10):801. doi: 10.1016/S2213-8587(20)30315-6.
4
Diabetes and COVID-19: Moving From News to Knowledge and a Glucose Hypothesis.糖尿病与新冠疫情：从新闻到知识及一个血糖假说
Diabetes Care. 2020 Oct;43(10):2336-2338. doi: 10.2337/dci20-0045. Epub 2020 Aug 4.
5
Prioritising action on diabetes during COVID-19.在2019冠状病毒病疫情期间优先采取糖尿病防治行动。
S Afr Med J. 2020 Jun 25;110(8):719-720.
6
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):666-667. doi: 10.1016/S2213-8587(20)30231-X.
7
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):669. doi: 10.1016/S2213-8587(20)30235-7.
8
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):668. doi: 10.1016/S2213-8587(20)30234-5.
9
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):667-668. doi: 10.1016/S2213-8587(20)30227-8.
10
Management of diabetes in patients with COVID-19.2019冠状病毒病患者的糖尿病管理
Lancet Diabetes Endocrinol. 2020 Aug;8(8):666. doi: 10.1016/S2213-8587(20)30226-6.
引用本文的文献
1
Relationship between periodontitis, type 2 diabetes mellitus and COVID-19 disease: a narrative review.牙周炎、2型糖尿病与新冠肺炎之间的关系：一项叙述性综述
Front Cell Infect Microbiol. 2025 May 8;15:1527217. doi: 10.3389/fcimb.2025.1527217. eCollection 2025.
2
A qualitative evaluation of the national rollout of a diabetes prevention programme in England.英格兰国家推广糖尿病预防计划的定性评估。
BMC Health Serv Res. 2023 Sep 29;23(1):1043. doi: 10.1186/s12913-023-10002-y.
3
COVID-19 Outcomes and Diabetes Mellitus: A Comprehensive Multicenter Prospective Cohort Study.2019冠状病毒病的转归与糖尿病：一项多中心前瞻性队列综合研究
Microorganisms. 2023 May 27;11(6):1416. doi: 10.3390/microorganisms11061416.
4
The Impact of the Covid-19 Pandemic on the Well-Being and Diabetes Management of Adolescents With Type 1 Diabetes and Their Caregivers: A Scoping Review.2019年冠状病毒病大流行对1型糖尿病青少年及其照顾者的幸福感和糖尿病管理的影响：一项范围综述
Front Clin Diabetes Healthc. 2022 Mar 8;3:835598. doi: 10.3389/fcdhc.2022.835598. eCollection 2022.
5
Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches.探索西格列汀治疗 2 型糖尿病的新靶点：网络药理学、分子对接、分子动力学模拟和 SPR 方法。
Front Endocrinol (Lausanne). 2023 Jan 9;13:1096655. doi: 10.3389/fendo.2022.1096655. eCollection 2022.
6
COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management.2019冠状病毒病与糖尿病：从病理生理学到临床管理
Cureus. 2022 Nov 25;14(11):e31895. doi: 10.7759/cureus.31895. eCollection 2022 Nov.
7
Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: The AMD annals initiative.在 COVID-19 大流行期间，远程医疗在 2 型糖尿病门诊患者中的作用：AMD 纪事倡议。
Diabetes Res Clin Pract. 2022 Dec;194:110158. doi: 10.1016/j.diabres.2022.110158. Epub 2022 Nov 15.
8
Economic hardships from COVID-19 and its association with socioeconomic factors and diabetes management indicators: A cross-sectional study.2019冠状病毒病带来的经济困难及其与社会经济因素和糖尿病管理指标的关联：一项横断面研究。
Heliyon. 2022 May 18;8(5):e09461. doi: 10.1016/j.heliyon.2022.e09461. eCollection 2022 May.
9
Telemedicine for the Clinical Management of Diabetes; Implications and Considerations After COVID-19 Experience.远程医疗在糖尿病临床管理中的应用；COVID-19 经验后的影响与思考。
High Blood Press Cardiovasc Prev. 2022 Jul;29(4):319-326. doi: 10.1007/s40292-022-00524-7. Epub 2022 May 17.
10
Plasma glucose levels and diabetes are independent predictors for mortality in patients with COVID-19.血浆葡萄糖水平和糖尿病是 COVID-19 患者死亡的独立预测因素。
Epidemiol Infect. 2022 May 16;150:e106. doi: 10.1017/S095026882200022X.
本文引用的文献
1
Clinical characteristics and outcomes of patients with severe covid-19 with diabetes.伴有糖尿病的重症 COVID-19 患者的临床特征和结局。
BMJ Open Diabetes Res Care. 2020 Apr;8(1). doi: 10.1136/bmjdrc-2020-001343.
2
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.2019 年冠状病毒病患者中某些基础健康状况的初步估计——美国，2020 年 2 月 12 日至 3 月 28 日。
MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2.
3
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.中国心血管代谢疾病对 COVID-19 的流行和影响。
Clin Res Cardiol. 2020 May;109(5):531-538. doi: 10.1007/s00392-020-01626-9. Epub 2020 Mar 11.
6
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
7
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情，该病毒可能来源于蝙蝠。
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
8
First Case of 2019 Novel Coronavirus in the United States.美国首例 2019 新型冠状病毒病例。
N Engl J Med. 2020 Mar 5;382(10):929-936. doi: 10.1056/NEJMoa2001191. Epub 2020 Jan 31.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件